Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abemaciclib in HPV-Negative HNSCC
NCT04169074Phase 2Terminated
- Sponsor
- University of Arizona
- Start
- Jul 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abemaciclib in head and neck squamous cell carcinoma (HNSCC), sponsored by University of Arizona. Started Jul 2021; status: terminated.
02
Drugs
abemaciclib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT04169074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04169074.